Comparison between the hybrid capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia

Journal of Clinical Microbiology

Volumn 43, Issue 7, 2005, Pages 3260-3266

  Söderlund Strand, Anna ^a   Rymark, Per ^b   Andersson, Pia ^c   Dillner, Joakim ^a   Dillner, Lena ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b Västmanland Hospital Vasteras   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; DIAGNOSTIC TEST; DIATHERMY; DOT HYBRIDIZATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 22144437747     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.7.3260-3266.2005     Document Type: Article

References (40)

1. Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. 2000. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J. Natl. Cancer Inst. 92:397-402.
2. Bergeron, C., D. Jeannel, J. D. Poveda, P. Cassonnet, and G. Orth. 2000. Human papillomavirus testing in women with mild cytologic atypia. Obstet. Gynecol. 95:821-827.
3. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah, et al. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
4. Bosch, F. X., and N. Munoz. 2002. The viral etiology of cervical cancer. Virus Res. 89:183-190.
5. Clavel, C., M. Masure, J. P. Bory, I. Putaud, C. Mangeonjean, M. Lorenzato, R. Gabriel, C. Quereux, and P. Birembaut. 1999. Hybrid capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br. J. Cancer 80:1306-1311.
6. Clavel, C., J. Cucherousset, M. Lorenzato, S. Caudroy, J. M. Nou, P. Nazeyrollas, M. Polette, J.-P. Bory, R. Gabriel, C. Quereux, and P. Birembaut. 2004. Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions. Br. J. Cancer 90:1803-1808.
7. Clifford, G. M., J. S. Smith, M. Plummer, N. Munoz, and S. Franceschi. 2003. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88:63-73.
8. Cuzick, J., E. Beverley, L. Ho, G. Terry, H. Sapper, I. Mielzynska, A. Lorincz, W. K. Chan, T. Krausz, and P. Soutter. 1999. HPV testing in primary screening of older women. Br. J. Cancer 81:554-558.
9. de Roda Busman, A.-M., J. M. M. Walboomers, A. J. C. van den Brule, C. J. L. M. Meijer, and P. J. F. Snijders. 1995. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76:1057-1062.
10. Distefano, A. L., M. A. Picconi, L. V. Alonio, D. Dalbert, J. Mural, O. Bartt, G. Bazan, G. Cervantes, M. Lizano, A. G. Carranca, and A. Teyssie. 1998. Persistence of human papillomavirus DNA in cervical lesions after treatment with diathermic large loop excision. Infect. Dis. Obstet. Gynecol. 6:214-219.
11. Elfgren, K., P. Bistoletti, L. Dillner, J. M. M. Walboomers, J. L. M. Meijer, and J. Dillner. 1996. Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens. Am. J. Obstet. Gynecol. 174:937-942.
12. Forslund, O., B. G. Hansson, P. Rymark, and B. Bjerre. 1993. Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples. J. Clin. Microbiol. 31:1975-1979.
13. Forslund, O., B. G. Hansson, and B. Bjerre. 1994. Typing of human papillomaviruses by consensus polymerase chain reaction and a non-radioactive reverse dot blot hybridization. J. Virol. Methods 49:129-139.
14. Gravitt, P. E., C. L. Peyton, T. Q. Alessi, C. M. Wheeler, F. Coutlee, A. Hildesheim, M. H. Schiffman, D. R. Scott, and R. J. Apple. 2000. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38:357-361.
15. Ho, G. Y. F., R. D. Burk, S. Klein, A. S. Radish, C. J. Chang, P. Palan, J. Basil, R. Tachezy, R. Lewis, and S. Romney. 1995. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. Natl. Cancer Inst. 87:1365-1371.
16. Ho, G. Y. F., R. Bierman, L. Beardsley, C. J. Chang, and R. D. Burk. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:423-428.
17. Houfflin Debarge, V., P. Collinet, D. Vinatier, A. Ego, A. Dewilde, F. Boman, and J. L. Leroy. 2003. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions. Gynecol. Oncol. 90:587-592.
18. +-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J. Clin. Microbiol. 35:791-795.
19. Jacobs, M. V., J. M. M. Walboomers, P. J. F. Snijders, F. J. Voorhorst, R. H. M. Verheuen, N. Fransen-Daalmeijer, and C. J. L. M. Meijer. 2000. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int. J. Cancer 87:221-227.
20. Koss, L. G. (ed). 1979. Diagnostic cytology and its histologic basis, 3rd ed. Lippincott, Philadelphia, Pa.
21. Koutsky, L. A., K. K. Holmes, C. W. Critchlow, C. E. Stevens, J. Paavonen, A. M. Beckmann, T. A. DeRouen, D. A. Galloway, D. Vernon, and N. B. Kiviat. 1992. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med. 327: 1272-1278.
22. MacMahon, S., R. Peto, J. Cutler, R. Collins, P. Sorlie, J. Neaton, R. Abbott, J. Godwin, A. Dyer, and J. Stamler. 1990. Blood pressure, stroke and coronary heart disease. Part 1. Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 335:765-774.
23. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsauge, K. V. Shah, P. J. F. Snijders, C. J. L. M. Meijer, et al. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
24. Nobbenhuis, M. A. E., J. M. M. Walboomers, T. J. M. Helmerhorst, L. Rozendaal, A. J. Remmink, E. K. J. Risse, H. C. van der Linden, F. J. Voorhorst, P. Kenemans, and C. J. L. M. Meyer. 1999. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354:20-25.
25. Nobbenhuis, M. A. E., T. J. M. Helmerhorst, A. J. C. van den Brule, L. Rozendaal, F. J. Voorhorst, P. D. Bezemer, R. H. M. Verheijen, and C. J. L. M. Meyer. 2001. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 358:1782-1783.
26. Nobbenhuis, M. A. E., C. J. L. M. Meijer, A. J. C. van den Brule, L. Rozendaal, F. J. Voorhorst, E. K. J. Rissa, R. H. M. Verheijen, and T. J. M. Helmerhorst. 2001. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br. J. Cancer 84:796-801.
27. Paraskevaidis, E., M. Arbyn, A. Sotiriadis, E. Diakomanolis, P. Martin-Hirsch, G. Koliopoulos, G. Makrydimas, J. Tofoski, and D. H. Roukos. 2004. The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat. Rev. 30:205-211.
28. Parkin, M., P. Pisani, and J. Ferlay. 1999. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80:827-841.
29. Petry, K. U., S. Menton, M. Menton, F. van Loenen-Frosch, H. de Carvalho Gomes, B. Holz, B. Schopp, S. Garbrecht-Buettner, P. Davies, G. Boehmer, E. van den Akker, and T. Iftner. 2003. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br. J. Cancer 88:1570-1577.
30. Peyton, C. L., M. Schiffman, A. T. Lörincz, W. C. Hunt, I. Mielzynska, C. Bratti, S. Eaton, A. Hildesheim, L. A. Morera, A. C. Rodriguez, R. Herrero, M. E. Sherman, and C. M. Wheeler. 1998. Comparison of PCR- and Hybrid Capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J. Clin. Microbiol. 36:3248-3254.
31. Poljak, M., A. Brencic, K. Seme, A. Vince, and I. J. Marin. 1999. Comparative evaluation of first- and second-generation Digene Hybrid Capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer. J. Clin. Microbiol. 37:796-797.
32. Romney, S. L., G. Y. F. Ho, P. R. Palan, J. Basu, A. S. Kadish, S. Klein, M. Mikhail, R. J. Hagan, C. J. Chang, and R. D. Burk. 1997. Effects of β-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection. Gynecol. Oncol. 65:483-492.
33. Rozendaal, L., J. M. M. Walboomers, J. C. van der Linden, F. J. Voorhorst, P. Kenemans, T. J. M. Helmerhorst, M. van Ballegooijen, and C. J. L. M. Meijer. 1996. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int. J. Cancer 68:766-769.
34. Schiffman, M. H., H. M. Bauer, R. N. Hoover, A. G. Glass, D. M. Cadell, B. B. Rush, D. R. Scott, M. E. Sherman, R. J. Kurman, S. Wacholder, C. K. Stanton, and M. M. Manos. 1993. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:958-964.
35. Schneede, P., P. Hillemanns, F. Ziller, A. Hofstetter, E. Stockfleth, R. Arndt, and T. Meyer. 2001. Evaluation of HPV testing by Hybrid Capture II for routine gynaecologic screening. Acta Obstet. Gynecol. Scand. 80:750-752.
36. Sherman, M. E., A. T. Lorincz, D. R. Scott, S. Wacholder, P. E. Castle, A. G. Glass, I. Mielzynska-Lohnas, B. B. Rush, and M. Schiffman. 2003. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J. Natl. Cancer Inst. 95:46-52.
37. Venturolli, S., M. Cricca, F. Bonvicini, F. Giosa, F. R. Pulvirenti, C. Galli, M. Musiani, and M. Zerbini. 2002. Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: concordance and correlation with cytological results. J. Clin. Virol. 25:177-185.
38. Vince, A., N. Kutela, J. Iscic-Bes, V. Harni, M. Ivanisevic, Z. Sonicki, Z. Culig, and M. Poljak. 2002. Clinical utility of molecular detection of human papillomavirus in cervical samples by hybrid capture technology. J. Clin. Virol. 25:109-112.
39. Walboomers, J. M. M., and C. J. L. M. Meijer. 1997. Do HPV-negative cervical carcinomas exist? J. Pathol. 181:253-254.
40. Walboomers, J. M. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. F. Snijders, J. Peto, C. J. L. M. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.